「for」の検索結果
125件：46～50件目を表示
-
al Announcement: September 3, 2024 Senju Pharmaceutical Co., Ltd. Acquisition of Marketing Approval for “ Mytear LUMIFY” Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuh...
https://www.senju.co.jp/system/files/content_news/2024-08/ENG_20240903_0.pdf -
Meetings of the Minds | Research & Development | SENJU Pharmaceutica
non-clinical ocular instillation toxicity studies of SJP-0132, a TRPV1 antagonist, a novel eye drop for dry eye disease Hideya Yonekura, Kotaro Yamada, Gen Suzuki, Yu Haranosono, Yoshinori Yamagiwa, I...
https://www.senju.co.jp/english/rd/society/ -
Overseas Activities | SENJU Pharmaceutical
d products, the licensing of product technologies and patents exceeds 50 countries. Quick action to form alliances and introduce cutting-edge technologies and information does not matter by region, in...
https://www.senju.co.jp/english/global/ -
Business Activities | About Senju | SENJU Pharmaceutical
ering path in ophthalmic pharmaceuticals. In the hope of developing even more original new products for the future, we have begun to take on the challenge of the five senses. Human innate instincts an...
https://www.senju.co.jp/english/about/business/ -
Business Activities | About Senju | SENJU Pharmaceutical
ering path in ophthalmic pharmaceuticals. In the hope of developing even more original new products for the future, we have begun to take on the challenge of the five senses. Human innate instincts an...
http://www.senju.co.jp/english/about/business/